A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Clinical trial NCT03038100 · COMPLETED
Trial details
- NCT number
- NCT03038100
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-08
- Primary completion
- 2022-02-08
- Enrollment
- 1301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.